Corticosteroids are the mainstay of treatment for polymyalgia rheumatica, ... National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). February 2022. Polymyalgia Rheumatica.

Polymyalgia rheumatica (PMR) is an inflammatory disease that causes pain and stiffness in major muscle groups of your body, often including your neck, shoulders, and hip area. It’s the most ...

Polymyalgia rheumatica is occasionally accompanied by sudden blindness ensuing upon relatively ... P. D. C., and McCallum, D. I. Skin manifestations of giant-cell arteritis. Brit. J. Dermal. 76: ...

Both polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA) are autoimmune conditions. They make your immune system attack your joints. These conditions have many similarities, but they have ...

Polymyalgia rheumatica and giant cell arteritis PMR is closely linked with an autoimmune disease called giant cell arteritis (GCA), which is an inflammatory condition affecting the arteries.

BARCELONA, Spain — Compared with placebo, adding methotrexate (MTX) to treatment for newly diagnosed polymyalgia rheumatica (PMR) nearly doubled glucocorticoid (GC)-free remission rates at 1 ...

The FDA recently approved sarilumab (Kevzara) for the treatment of adults with polymyalgia rheumatica (PMR) who had an inadequate response to corticosteroids (CS) or are unable to tolerate a CS taper.

Scientists have found success in treating a 'neglected' inflammatory condition, polymyalgia rheumatica, with a drug that could provide an alternative to steroids for patients.

Sun S, Shao X, Lu X, et al. Assessing the feasibility of SUVindex (a metric derived from FDG/PET/CT) for the diagnosis of polymyalgia rheumatica. Clinical Radiol . Published online June 28, 2023 ...

For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α ...

Polymyalgia Rheumatica could be safely, effectively treated with tofacitinib, avoiding the need for steroids, per new proof-of-concept Randomized Controlled Trial ...